Last updated on January 2019

Acute Gastric Variceal Bleeding: Endoscopic Treatment Versus BRTO

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Esophageal Varices
  • Age: Between 18 - 75 Years
  • Gender: Male or Female

Inclusion Criteria:

  1. Cirrhosis
  2. Active bleeding from gastric varices (GOV2 or IGV1)
  3. Presence of gastrorenal shunt

Exclusion Criteria:

  1. Previous pharmacologic therapy combined with endoscopic treatment to prevent rebleeding
  2. Previous use of TIPS or surgical shunt
  3. Non-cirrhotic portal hypertension
  4. Contraindications to cyanoacrylate injection or BRTO
  5. Portal cavernoma
  6. Hepatorenal syndrome
  7. Proven malignancy including hepatocellular carcinoma
  8. End-stage renal disease under renal replacement therapy;
  9. Cardiorespiratory failure
  10. Pregnancy or patients not giving informed consent for endoscopic procedures

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.